Gilead Sciences v NuCana: Lessons for parallel UK and EPO proceedings
Read more >
Featured Insights: pharmaceutical
First insights into the UPC patent litigation in Europe
Read more >
One rule for one, one for another – patent term of pharmaceutical patents truncated in B...
Read more >
The slow death of Neurim – will SPCs for new indications soon be a thing of the past...
Read more >
